Phoenixkinetics
1 known investors
Phoenix Kinetics develops the NUsurface meniscus implant, a device that preserves knee motion and provides pain relief for patients with early knee osteoarthritis who fall between meniscal allograft transplantation and total knee replacement. The company targets an estimated U.S. patient population of over one million and has run clinical trials demonstrating pain reduction and improved physical function.
HardwareHealthtechMedical Devices
Founders & leadership
RB
Ryan BelaneyCEO
AK
Adam KlyceVP of Marketing & Communications
KH
Kirk HansonVP of Medical Education and Clinical Operations